STERIS Appoints Pierre Boulud to Board of Directors
STERIS plc has appointed Pierre Boulud to its Board of Directors, effective May 5, 2026. Boulud, currently the CEO of bioMérieux and with extensive experience in operational and strategic leadership, is expected to bring significant insight to the board. The announcement was made by Mohsen Sohi, Chairman of STERIS.
DUBLIN, IRELAND, May 07, 2026 (GLOBE NEWSWIRE) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that, effective May 5, 2026, Pierre Boulud has been appointed to the Board of Directors.